Novel flucytosine loaded in-situ gel for the management of ocular infections

Komal Parmar; Rishi Bharatia

doi:10.56782/pps.350

Published : 2025-08-06

Vol. 23 No. 3 (2025)

Novel flucytosine loaded in-situ gel for the management of ocular infections

Komal Parmar

Rishi Bharatia

DOI: https://doi.org/10.56782/pps.350

Abstract

Flucytosine, a BCS class II drug, is indicated in fungal infection. Currently, flucytosine is available in tablet dosage form in the market. However, the drug is indicated for the ocular fungal infections. Thus, there is a need to develop a ocular formulation that can retain for longer duration with prolonged drug release. In the present work, in-situ ocular gel containing flucytosine was prepared for cryptococcosis and candidiasis fungal infection. Design of experiment was employed to obtain the optimized formulation. To determine the independent variables impacting the formulation preparation, preliminary trials were conducted using Poloxamer 407, Poloxamer 188, Carbopol 934, gellan gum, and HPMC K4M as polymer and it was optimized using Simplex lattice design. Amount of poloxamer 407, amount of gellan gum and amount of HPMC K4M were taken as independent variable while viscosity (cps), gelling time (sec), drug release in 6 h were taken as dependent variables. The prepared formulations were evaluated for clarity, pH, viscosity, gelling time, gelling strength, gelling temperature, in-vitro drug release, sterility test and stability studies. Results of the prepared in-situ ocular gel formulation of flucytosine demonstrated significant potential as a therapeutic breakthrough for enhancing treatment outcomes in candidiasis and cryptococcosis infections. Stability studies suggested formulation was stable for at least 6 months. Thus, a successful formulation of flucytosine was developed addressing critical challenges of conventional eye drops and offering prolonged drug release with improved retention in the eye.

Keywords:

Flucytosine, Poloxamer 407, Gellan gum, HPMC K4M, In-situ ocular gel, Simplex lattice design

Similar Articles

Lucky Vasave, Shivraj Jadhav, Rushikesh Bachhav, Sunil Mahajan, Deepak Sonawane, A Formulation and Evaluation of Gastro-retentive In-Situ Gel of Anti-Ulcer Drug Misoprostol , Prospects in Pharmaceutical Sciences: No. 2025 (Early Access)
Mateusz Kawka, Maciej Pilarek, Katarzyna Sykłowska-Baranek, Agnieszka Pietrosiuk, IN SITU EXTRACTION OF PLANT SECONDARY METABOLITES , Prospects in Pharmaceutical Sciences: Vol. 15 No. 7 (2017)
Pratiksha Nahar, Dinesh Patil, Yash Bachhav, Jayesh Musale, Pallavi Bachhav, Design and Characterization of a Gastro-Retentive Floating Atorvastatin Calcium Tablet , Prospects in Pharmaceutical Sciences: Vol. 23 No. 3 (2025)
Sailaja Gunnam, Sindhura T, Rajeswari Aleti, Monika Nijhawan, Bi-layer tablets of sitagliptin phosphate & metformin hydrochloride – preparation and evaluation , Prospects in Pharmaceutical Sciences: Vol. 23 No. 3 (2025)
Rushikesh Mahale, Shivraj Jadhav, Sunil Mahajan, Development and optimization of gastro retentive floating tablets of dapsone for controlled release , Prospects in Pharmaceutical Sciences: No. 2025 (Early Access)
JITENDRA GAJBE, Dr.Ashwini R Madgulkar, Ms. Minakshi Shinde, Development of a UV Spectroscopy Method to Validate p-Coumaric Acid and Assess the Antioxidant Activity of a p-Coumaric Acid Gel Product. , Prospects in Pharmaceutical Sciences: No. 2025 (Early Access)
Priya Jagtap, Dr. Reshma Jadhav, Dr. Ashish Jain, Bhavesh Mahajan, Prapti Gawand, Prathamesh Chaudhari, Aishwarya Patil, QUALITY BY DESIGN APPROACH IN HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION OF ABIRATERONE ACETATE AND PREDNISOLONE WITH GREENNESS ASSESSMENT , Prospects in Pharmaceutical Sciences: No. 2025 (Early Access)
Monika Pawłowska, DESIGN AND PROPERTIES ANALYSIS OF MOLECULARLY IMPRINTED POLYMERS. MOLECULAR MODELING METHOD APPLICATION , Prospects in Pharmaceutical Sciences: Vol. 10 No. 2 (2012)
Ewa Napiórkowska, Overview of cyclodextrins and medicinal products containing cyclodextrins currently registered in Poland , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
Katarzyna Łysiak, Anna Łysiak, Barbara Maziarz, Paulina Przywara, Natalia Bogumiłło, Kinga Ściurka, Julia Ignacak, Mikołaj Borek, The use of botulinum toxin in ophthalmology , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)

1 2 3 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF

Citation rules

Parmar, K., & Bharatia, R. (2025). Novel flucytosine loaded in-situ gel for the management of ocular infections. Prospects in Pharmaceutical Sciences, 23(3), 75–83. https://doi.org/10.56782/pps.350

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

1. Vulovic, N.; Primprac, M.; Stupar, M.; Ford J.L. Some studies on the preservation of indomethacin suspensions intended for ophthalmic use. Int. J. Pharm. 1989, 55(2-3), 123-128. DOI: 10.1016/0378-5173(89)90032-X

2. Gebhardt, B.M.; Varnell, E.D.; Kaufman, H.E. Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection. J. Ocul. Pharmacol. Ther. 1995, 11, 509–517. DOI: 10.1089/jop.1995.11.509

3. Vandamme, T.F. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog. Retin. Eye Res. 2002, 21, 15–34. DOI: 10.1016/s1350-9462(01)00017-9

4. Lang, J.; Roehrs, R.; Jani, R. The Science and Practice of Pharmacy. In Remington, 7th ed, Lippincott Williams & Wilkins, Philadelphia, 2009, Volume 7, pp. 827-856.

5. Eguchi, H.; Shiota, H.; Oguro, S.; Kasama, T. The inhibitory effect of vancomycin ointment on the manifestation of MRSA keratitis in rabbits. J. Infect. Chemother. 2009, 15, 279–283. DOI: 10.1007/s10156-009-0708-6

6. Gray, C. Systemic toxicity with topical ophthalmic medications in children. Paediatr. Perinat. Drug Ther. 2006, 7, 23-29. DOI: 10.1185/146300905X75334

7. Ishibashi, T.; Yokoi, N.; Kinoshita, S. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J. Glaucom. 2003, 12, 486–490. DOI: 10.1097/00061198-200312000-00008

8. Giri, B.R.; Jakka, D.; Sandoval, M.A.; Kulkarni, V.R.; Bao, Q. Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies. Pharmaceutics 2024, 62, Art. No: 1325. DOI: 10.3390/pharmaceutics 16101325

9. Bonacucina, G.; Cespi, M.; Mencarelli, G.; Giorgioni, G.; Palmieri, G.F. Thermosensitive Self-Assembling Block Copolymers as Drug Delivery Systems. Polymers 2011, 3, 779-811. DOI: 10.3390/polym3020779

10. Del Amo, E.M.; Urtti, A. Current and future ophthalmic drug delivery systems. A shift to the posterior segment,” Drug Discov. Today 2008, 3, 135-143. DOI: 10.1016/j.drudis.2007. 11.002

11. Gupta, H.; Aqil, M. Contact lenses in ocular therapeutics,” Drug Discov. Today 2012, 17, 522-527. DOI: 10.1016/j.drudis.2012.01.014

12. Gurny, R.; Ibrahim, H.; Buri, P. The development & use of in situ formed gel triggered by pH. In Biopharmaceutics of ocular drug delivery, CRC Pres, 1992, pp. 81-90.

13. Cohen, S.; Lobel, E.; Trevgoda, A.; Peled, Y. A novel in situ forming ophthalmic drug delivery system from alginates undergoing gelling in the eye. J. Control. Release 1997, 44, 201–208. DOI: 10.1016/S0168-3659(96)01523-4

14. Srividya, B.; Cardoza, R.M.; Amin, P.D. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system,” J. Control. Release 2001, 73, 205-211. DOI: 10.1016/s0168-3659(01)00279-6

15. Qiu, Y.; Park, K. Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. 2001, 53, 321-339. DOI: 10.1016/ s0169-409x(01)00203-4

16. Mottu, F.; Gailloud, P.; Massuelle, D.; Rüfenacht, D.A.; Doelker, E. In vitro assessment of new embolic liquids prepared from preformed polymers and water-miscible solvents for aneurysm treatment. Biomaterials 2000, 21, 803-811. DOI: 10.1016/s0142-9612(99)00243-4

17. Burkoth, A.K.; Anseth, K.S. A review of photocrosslinked polyanhydrides: in situ forming degradable networks. Biomaterials. 2000, 21, 2395-2404. DOI: 10.1016/s0142-9612(00)00107-1

18. Podual, K.; Doyle, F.J. 3rd.; Peppas, N.A. Dynamic behavior of glucose oxidase-containing microparticles of poly(ethylene glycol)-grafted cationic hydrogels in an environment of changing pH. Biomaterials 2000, 21, 1439-1450. DOI: 10.1016/s0142-9612(00)00020-x

19. Guo, J.H.; Skinner, G.W.; Harcum, W.W.; Barnum, P.E.; Pharmaceutical applications of naturally occurring water soluble polymers. Pharm. Sci. & Technol. Today 1998, 1, 54-61. DOI: 10.1016/S1461-5347(98)00072-8

20. Aderman, C.M.; Gorovoy, I.R.; Chao, D.L.; Bloomer, M.M.; Obeid, A.; Stewart, J.M. Cryptococcal choroiditis in advanced AIDS with clinicopathologic correlation. Am. J. Ophthalmol. Case Rep. 2018, 10, 51-54. DOI: 10.1016/j.ajoc.2018.01.045

21. Phongkhun, K.; Pothikamjorn, T.; Srisurapanont, K.; Manothummetha, K.; Sanguankeo, A.; Thongkam, A.; Chuleerarux, N.; Leksuwankun, S.; Meejun, T.; Thanakitcharu, J.; Walker, M.; Gopinath, S.; Torvorapanit, P.; Langsiri, N.; Worasilchai, N.; Moonla, C.; Plongla, R.; Kates, O.S.; Nematollahi, S.; Permpalung, N. Prevalence of Ocular Candidiasis and Candida Endophthalmitis in Patients With Candidemia: A Systematic Review and Meta-Analysis. Clin. Infect. Dis. 2023, 76, 1738-1749. DOI: 10.1093/cid/ciad064

22. Vermes, A.; Guchelaar, H.J.; Dankert, J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J. Antimicrob. Chemother. 2000, 46, 171–179. DOI: 10.1093/jac/46.2.171

23. Prausnitz, M.R.; Noonan, J.S. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J. Pharm. Sci. 1998, 87, 1479–1488. DOI: 10.1021/js9802594

24. Liu, Y.; Liu, J.; Zhang, X.; Zhang, R.; Huang, Y.; Wu, C. In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery. AAPS PharmSciTech. 2010, 11, 610-620. DOI: 10.1208/s12249-010-9413-0

25. Politis, N.S.; Colombo, P.; Colombo, G.; Rekkas, M.D. Design of experiments (DoE) in pharmaceutical development. Drug Dev. Ind. Pharm. 2017, 43, 889-901. DOI: 10.1080/03639045.2017.1291672

26. Fukuda, I.M.; Pinto, C.F.F.; Moreira, C.; Saviano, A.M.; Lourenço, F.R. Design of Experiments (DoE) applied to Pharmaceutical and Analytical Quality by Design (QbD). Brazilian J. Pharm. Sci. 2018, 54(spe), Art. No: e01006. DOI: 10.1590/s2175-97902018000001006

27. Nair, A.B.; Shah, J.; Jacob, S.; Al-Dhubiab, B.E.; Sreeharsha, N.; Morsy, M.A.; Gupta, S.; Attimarad, M.; Shinu, P.; Venugopala, K.N. Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections. PLoS One 2021, 16, Art. No: e02488571. DOI: 10.1371/journal.pone.0248857

28. Mandlik, S.K.; Saugat, A.; Ameya, A.D. Application of simplex Lattice design in formulation and development of buoyant matrices of dipyridamole. J. App. Pharm. Sci. 2012, 2, 107-111. DOI: 10.7324/JAPS.2012.21221

29. Jeswani, G.; Chablani, L.; Gupta, U.; Sahoo, R.K.; Nakhate, K.T.; Ajazuddin. Development and optimization of paclitaxel loaded Eudragit/PLGA nanoparticles by simplex lattice mixture design: Exploration of improved hemocompatibility and in vivo kinetics. Biomed. Pharmacother. 2021, 144, Art. No: 112286. DOI: 10.1016/j.biopha.2021.112286

30. Nasser, N.; Hathout, R.M.; Abd-Allah, H.; Sammour, O.A. Simplex Lattice Design and Machine Learning Methods for the Optimization of Novel Microemulsion Systems to Enhance p-Coumaric Acid Oral Bioavailability: In Vitro and In Vivo Studies. AAPS PharmSciTech. 2024, 25, Art. No: 56. DOI: 10.1208/s12249-024-02766-1

31. Wu, Y.; Liu, Y.; Li, X.; Kebebe, D.; Zhang, B.; Ren, J.; Lu, J.; Li, J.; Du, S.; Liu, Z. Research progress of in-situ gelling ophthalmic drug delivery system. Asian J. Pharm. Sci. 2019, 14, 1-15. DOI: 10.1016/j.ajps.2018.04.008

32. Janga, K.Y.; Tatke, A.; Balguri, S.P.; Lamichanne, S.P.; Ibrahim, M.M.; Maria, D.N.; Jablonski, M.M.; Majumdar, S. Ion-sensitive in situ hydrogels of natamycin bilosomes for enhanced and prolonged ocular pharmacotherapy: in vitro permeability, cytotoxicity and in vivo evaluation. Artif. Cells Nanomed. Biotechnol. 2018, 46, 1039-1050. DOI: 10.1080/21691401.2018. 1443117

33. Hu, Y.; Wu, W. Application of Membrane Filtration to Cold Sterilization of Drinks and Establishment of Aseptic Workshop. Food Environ. Virol. 2023, 15, 89-106. DOI: 10.1007/s12560-023-09551-6

34. Çoban, Ö.; Pınar, S.G.; Polat, H.K.; Gedik, G.; Karakuyu, N.F.; Pezik, E.; Ünal, S.; Mokhtare, B.; Akşit, A. Development of Lacosamide-loaded In-Situ Gels through Experimental Design for Evaluation of Ocular Irritation In Vitro and In Vivo. J. Nanomed. 2020, 3, Art. No: 1031. DOI: 10.1016/j.xphs.2024.11.027

35. Sheshala, R.; Wai, N.Z.; Said, I.D.; Ashraf, K.; Lim, S.M.; Ramasamy, K.; Zeeshan, F. Poloxamer and Chitosan-Based In Situ Gels Loaded with Orthosiphon stamineus Benth. Extracts Containing Rosmarinic Acid for the Treatment of Ocular Infections. Turk. J. Pharm. Sci. 2022, 19, 671-680. DOI: 10.4274/tjps.galenos.2021.40121

36. Shanmugam, S.; Valarmathi, S.; Satheesh, K. Sterility Testing Procedure of Ophthalmic Ocusert Aciclovir Used For Treating Herpes Simplex Virus. Asian J. Pharm. Clin. Res. 2017, 10, 344-346. DOI: 10.22159/ajpcr.2017.v10i10.19216

37. Gupta, H.; Malik, A.; Khar, R.K.; Ali, A.; Bhatnagar, A.; Mittal, G. Physiologically active hydrogel (in situ gel) of sparfloxacin and its evaluation for ocular retention using gamma scintigraphy. J. Pharm. Bioallied. Sci. 2015, 7, 195-200. DOI: 10.4103/0975-7406.160015.

38. Kurniawansyah, I.S.; Rusdiana, T.; Sopyan, I.; Ramoko, H.; Wahab, H.A.; Subarnas, A. In situ ophthalmic gel forming systems of poloxamer 407 and hydroxypropyl methyl cellulose mixtures for sustained ocular delivery of chloramphenicole: optimization study by factorial design. Heliyon 2020, 6, Art. No: e05365. DOI: 10.1016/j.heliyon.2020.e05365.

39. Gunasekaran, S.; Seshadri, S.; Muthu, S. Vibrational spectra and normal coordinate analysis of flucytosine. Indian J. Pure Appl. Phy. 2006, 44, 581-586. URL: https://nopr.niscpr.res.in/handle/123456789/8338

40. Segall, A.I. Preformulation: The use of FTIR in compatibility studies. J. Innov. Appl. Pharm. Sci. 2019, 4(3), 01-06. URL: https://saapjournals.org/index.php/jiaps/article/view/198.

41. Biswal, S.; Parmanik, A.; Das, D.; Sahoo, R.N.; Nayak, A.K. Gellan gum-based in-situ gel formulations for ocular drug delivery: A practical approach. Int. J. Biolog. Macromol. 2024, 19, Art. No: 138979. DOI: 10.1016/j.ijbiomac.2024.138979

42. Garala, K.; Joshi, P.; Shah, M.; Ramkishan, A.; Patel, J. Formulation and evaluation of periodontal in situ gel. Int. J. Pharm. Investig. 2013, 3, 29-41. DOI: 10.4103/2230-973X.108961

43. Khare, P.; Chogale, M.M.; Kakade, P.; Patravale, V.B.; Gellan gum-based in situ gelling ophthalmic nanosuspension of Posaconazole. Drug Deliv. Transl. Res. 2022, 12, 2920-2935. DOI: 10.1007/s13346-022-01155-0

44. Satyanarayana, S.D.; Abu Lila, A.S.; Moin, A.; Moglad, E.H.; Khafagy, E.S.; Alotaibi, H.F.; Obaidullah, A.J.; Charyulu, R.N. Ocular Delivery of Bimatoprost-Loaded Solid Lipid Nanoparticles for Effective Management of Glaucoma. Pharmaceuticals (Basel) 2023, 16, Art. No: 1001. DOI: 10.3390/ph16071001

Komal Parmar

komal.parmar2385@gmail.com

Affiliation:

a:1:{s:5:"en_US";s:81:"ROFEL Shri G.M. Bilakhia College of Pharmacy, Rajju Shroff ROFEL University, Vapi";} India